Skip to Content

267 NL75 (Indomethacin Extended-Release 75 mg)

Pill with imprint 267 NL75 is White, Capsule-shape and has been identified as Indomethacin Extended-Release 75 mg. It is supplied by Ingenus Pharmaceuticals, LLC.

Indomethacin is used in the treatment of gout, acute; back pain; ankylosing spondylitis; bartter syndrome; bursitis (and more), and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 267 NL75

Indomethacin Extended-Release

Imprint:
267 NL75
Strength:
75 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory drugs
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Ingenus Pharmaceuticals, LLC
Manufacturer:
Novast Laboratories, Ltd.
National Drug Code (NDC):
50742-0234

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide